EMD Millipore, the Life Science division of Merck KGaA, has entered an agreement with Plasticell to distribute a single-application osteogenic medium discovered using the CombiCult screening system.   The osteogenic medium is serum- and xeno- free, more consistent and more potent than currently available formulations, according to the company. EMD Millipore has secured a license to distribute the medium globally for research purposes and Plasticell retains full rights for therapeutic application...